Clinical ResearchBiomarkers in Valve DiseaseProspective Validation of the Prognostic Usefulness of B-Type Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Aortic Regurgitation
Biomarkers in Valve Disease
Under an Elsevier user license
open archive
Key Words
aortic regurgitation
BNP
echocardiography
Abbreviations and Acronyms
AR
aortic regurgitation
BNP
B-type natriuretic peptide
CHF
congestive heart failure
CI
confidence interval
EDD
end-diastolic diameter
EDD/BSA
end-diastolic diameter indexed according to body surface area
EF
ejection fraction
EROA
effective regurgitant orifice area
ESD/BSA
end-systolic diameter indexed according to body surface area
HR
hazard ratio
IDI
integrated discrimination improvement
IQR
interquartile range
LV
left ventricular
LVD
left ventricular dysfunction
LVDSD
left ventricular systolic dysfunction symptoms or death
MET
metabolic equivalent
NT-proBNP
N-terminal pro–B-type natriuretic peptide
OR
odds ratio
PWTd
posterior wall thickness in diastole
PWTs
posterior wall thickness in systole
ROC
receiver-operator characteristic
RV
regurgitant volume
SBP
systolic blood pressure
WS
wall stress
Cited by (0)
All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.